-
Signature
-
Kaushik Ghoshal, Chief Commercial Officer, SaaS business
-
Stock symbol
-
RMD
-
Transactions as of
-
Mar 10, 2025
-
Transactions value $
-
-$514,344
-
Form type
-
4
-
Date filed
-
3/11/2025, 04:19 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$24.7K |
+169 |
+1.74% |
$146.34 |
9.89K |
Mar 10, 2025 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$22.2K |
+105 |
+1.06% |
$211.76 |
10K |
Mar 10, 2025 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$525K |
+3.59K |
+35.89% |
$146.34 |
13.6K |
Mar 10, 2025 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$1.25M |
+5.88K |
+43.29% |
$211.76 |
19.5K |
Mar 10, 2025 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Sale |
-$2.33M |
-9.75K |
-50.05% |
$239.31 |
9.73K |
Mar 10, 2025 |
Direct |
F1, F2 |
| holding |
RMD |
ResMed Common Stock |
|
|
|
|
|
9.63K |
Mar 10, 2025 |
Kaushik Ghoshal and Jayati Ghoshal Family Trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-169 |
-100% |
$0.00 |
0 |
Mar 10, 2025 |
ResMed Common Stock |
169 |
$146.34 |
Direct |
F1, F3 |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-105 |
-100% |
$0.00 |
0 |
Mar 10, 2025 |
ResMed Common Stock |
105 |
$211.76 |
Direct |
F1, F3 |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-5.88K |
-100% |
$0.00 |
0 |
Mar 10, 2025 |
ResMed Common Stock |
5.88K |
$211.76 |
Direct |
F1, F3 |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-3.59K |
-100% |
$0.00 |
0 |
Mar 10, 2025 |
ResMed Common Stock |
3.59K |
$146.34 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: